The promoter group holds 57.68 percent stake while the bloc of private equity investors holds 31.52 percent in SRL Diagnostics. The investors include the likes of NY Jacob Ballas and the World Bank's ...
There is also a growing trend of tracking vital parameters through smart wearables, especially among the young. This will also propel the preventive testing market as people want to keep a tab on ...
COVID-19 proved to be a dampener for most businesses. However, healthcare, pharma and diagnostics in particular, had a different story to tell. SRL Diagnostics, with a chain of over 400 testing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback